PL1718337T3 - Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem - Google Patents

Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem

Info

Publication number
PL1718337T3
PL1718337T3 PL05702484T PL05702484T PL1718337T3 PL 1718337 T3 PL1718337 T3 PL 1718337T3 PL 05702484 T PL05702484 T PL 05702484T PL 05702484 T PL05702484 T PL 05702484T PL 1718337 T3 PL1718337 T3 PL 1718337T3
Authority
PL
Poland
Prior art keywords
dexecadotril
racecadotril
receptor antagonist
new combinations
combinations
Prior art date
Application number
PL05702484T
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1718337(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Publication of PL1718337T3 publication Critical patent/PL1718337T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PL05702484T 2004-02-12 2005-02-14 Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem PL1718337T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor
PCT/IB2005/000351 WO2005079850A1 (en) 2004-02-12 2005-02-14 New combinations of an anti emetic agent and an enkephalinase inhibitor
EP05702484A EP1718337B1 (en) 2004-02-12 2005-02-14 New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril

Publications (1)

Publication Number Publication Date
PL1718337T3 true PL1718337T3 (pl) 2010-09-30

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05702484T PL1718337T3 (pl) 2004-02-12 2005-02-14 Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem

Country Status (28)

Country Link
US (1) US8222294B2 (pl)
EP (2) EP1563848A1 (pl)
JP (1) JP4987487B2 (pl)
KR (1) KR101152308B1 (pl)
CN (1) CN1917903B (pl)
AT (1) ATE468138T1 (pl)
AU (1) AU2005215262B2 (pl)
BR (1) BRPI0506631B8 (pl)
CA (1) CA2553827C (pl)
CY (1) CY1110202T1 (pl)
DE (1) DE602005021317D1 (pl)
DK (1) DK1718337T3 (pl)
EA (1) EA010625B1 (pl)
EC (1) ECSP066758A (pl)
ES (1) ES2344909T3 (pl)
HR (1) HRP20100363T1 (pl)
MA (1) MA28354A1 (pl)
ME (1) ME01175B (pl)
NO (1) NO337320B1 (pl)
NZ (1) NZ548635A (pl)
PL (1) PL1718337T3 (pl)
PT (1) PT1718337E (pl)
RS (1) RS51329B (pl)
SI (1) SI1718337T1 (pl)
TN (1) TNSN06246A1 (pl)
UA (1) UA88156C2 (pl)
WO (1) WO2005079850A1 (pl)
ZA (1) ZA200605872B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
PT2866802T (pt) * 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
JP4987487B2 (ja) 2012-07-25
NZ548635A (en) 2009-10-30
CN1917903A (zh) 2007-02-21
ZA200605872B (en) 2008-01-08
EP1563848A1 (en) 2005-08-17
EP1718337B1 (en) 2010-05-19
EP1718337A1 (en) 2006-11-08
US8222294B2 (en) 2012-07-17
DE602005021317D1 (de) 2010-07-01
JP2007522202A (ja) 2007-08-09
HRP20100363T1 (hr) 2010-07-31
CY1110202T1 (el) 2015-01-14
NO337320B1 (no) 2016-03-07
CA2553827A1 (en) 2005-09-01
US20070275993A1 (en) 2007-11-29
RS51329B (en) 2011-02-28
UA88156C2 (ru) 2009-09-25
CN1917903B (zh) 2010-07-21
KR20060132691A (ko) 2006-12-21
MA28354A1 (fr) 2006-12-01
TNSN06246A1 (fr) 2007-12-03
BRPI0506631B8 (pt) 2021-05-25
EA010625B1 (ru) 2008-10-30
BRPI0506631B1 (pt) 2018-12-04
EA200601466A1 (ru) 2006-12-29
BRPI0506631A (pt) 2007-05-08
KR101152308B1 (ko) 2012-06-11
PT1718337E (pt) 2010-06-16
WO2005079850A1 (en) 2005-09-01
ATE468138T1 (de) 2010-06-15
AU2005215262A1 (en) 2005-09-01
CA2553827C (en) 2012-08-07
SI1718337T1 (sl) 2010-08-31
DK1718337T3 (da) 2010-07-26
AU2005215262B2 (en) 2011-03-03
ES2344909T3 (es) 2010-09-09
ME01175B (me) 2013-03-20
ECSP066758A (es) 2006-11-24
NO20063973L (no) 2006-09-05

Similar Documents

Publication Publication Date Title
SI1718337T1 (sl) Nove kombinacije antagonista receptorja 5-HT3 z racecadotrilom ali deksecadotrilom
ATE479687T1 (de) Kinaseinhibitoren
DK1704859T3 (da) Kontrol af androgen receptor-afhængig genenkspression ved inhibering af amin-oxidase-aktiviteten af lysin-specifik demetylase (LSD1)
DK1836201T3 (da) Pyrrolidininhibitorer af IAP
HRP20130891T1 (en) DGAT inhibitor
GB2453058A (en) Kinase antagonists
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
PT2260875E (pt) Agentes de imagiologia direcionados para recetor de folato
WO2009089260A3 (en) Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
MY133335A (en) Photoresist compositions
MX2009005217A (es) Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos.
UA85505C2 (en) Kinase inhibitors
EP2101772A4 (en) NEUROMUSCULAR BLOCKAGE AGENTS WITH INTERMEDIATE DURATION AND THEIR ANTAGONISTS
NO20070211L (no) Kationiske polymerer som inneholder 2-hydroksyetyl-metakrylsyre som akseleratorer for ASA-liming
TN2009000091A1 (en) Nitrogen containing substituted heterocycles as platelet adp receptor inhibitors
MX2009004269A (es) Inhibidores de cinasa mapk/erk.
ATE423765T1 (de) Ep2-rezeptoragonisten
WO2009114856A3 (en) Aurora kinase inhibitors
ES2981250T3 (es) Terapia combinada con un inhibidor de IDH mutante
TW200745187A (en) Protecting agent
WO2007002842A3 (en) Substituted n-cinnamyl benzamides
WO2005048999A3 (en) Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders
TN2009000008A1 (en) Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
TW200615292A (en) Additives for epoxy resins
TH74483A (th) ตัวปรับของแอนโดรเจนรีเซพเตอร์